Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
Add to list
  1. Search results
  2. Development of monoclonal antibodies ...

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs

SF De Meyer, K Vanhoorelbeke, H Ulrichts, S Staelens, Hendrik Feys (UGent) , I Salles, A Fontayne and H Deckmyn
(2006) CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS. 6(3). p.191-207
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
De Meyer, SF, et al. “Development of Monoclonal Antibodies That Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs.” CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS, vol. 6, no. 3, 2006, pp. 191–207, doi:10.2174/187152906778249536.
APA
De Meyer, S., Vanhoorelbeke, K., Ulrichts, H., Staelens, S., Feys, H., Salles, I., … Deckmyn, H. (2006). Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs. CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS, 6(3), 191–207. https://doi.org/10.2174/187152906778249536
Chicago author-date
De Meyer, SF, K Vanhoorelbeke, H Ulrichts, S Staelens, Hendrik Feys, I Salles, A Fontayne, and H Deckmyn. 2006. “Development of Monoclonal Antibodies That Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs.” CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS 6 (3): 191–207. https://doi.org/10.2174/187152906778249536.
Chicago author-date (all authors)
De Meyer, SF, K Vanhoorelbeke, H Ulrichts, S Staelens, Hendrik Feys, I Salles, A Fontayne, and H Deckmyn. 2006. “Development of Monoclonal Antibodies That Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs.” CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS 6 (3): 191–207. doi:10.2174/187152906778249536.
Vancouver
1.
De Meyer S, Vanhoorelbeke K, Ulrichts H, Staelens S, Feys H, Salles I, et al. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs. CARDIOVASCULAR & HEMATOLOGICAL DISORDERS DRUG TARGETS. 2006;6(3):191–207.
IEEE
[1]
S. De Meyer et al., “Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs,” CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS, vol. 6, no. 3, pp. 191–207, 2006.
@article{8549121,
  author       = {{De Meyer, SF and Vanhoorelbeke, K and Ulrichts, H and Staelens, S and Feys, Hendrik and Salles, I and Fontayne, A and Deckmyn, H}},
  issn         = {{1871-529X}},
  journal      = {{CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{191--207}},
  title        = {{Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs}},
  url          = {{http://doi.org/10.2174/187152906778249536}},
  volume       = {{6}},
  year         = {{2006}},
}
Altmetric
View in Altmetric